Safex Chemicals India IPO Details
MAINBOARD
Safex Chemicals India IPO DRHP (Draft Red Herring Prospectus) has been SEBI Approval Received.
Offer for Sale consists of 3,57,34,818 shares .
The Lead Managers for Safex Chemicals India IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Axis Capital Ltd, Jm Financial Ltd, SBI Capital Markets Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Safex Chemicals India Limited DRHP.
Safex Chemicals India IPO Details
Safex Chemicals India IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
To be announced | |||
Safex Chemicals India IPO Reservation
Promoter Holding
Documents
Safex Chemicals India IPO Valuations
Safex Chemicals India Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 2,084.36 | 1,923.43 | 1,905.17 |
| Revenue | 1,605.82 | 1,417.66 | 1,167.47 |
| Profit After Tax | -14.29 | -22.79 | -1.02 |
| EBITDA | 233.03 | 118.65 | 149.06 |
| Net Worth | 611.46 | 626.15 | 648.88 |
| Reserves and Surplus | 656.47 | 657.84 | 664.85 |
| Total Borrowing | 830.39 | 677.09 | 680.22 |
| Amount in ₹ Crore | |||
About Safex Chemicals India IPO
Incorporated in January 1991, Safex Chemicals (India) Ltd is a speciality chemicals company focused on agrochemicals and active across the agrochemical value chain.
The company operates in three verticals: branded formulation, specialty chemicals, and CDMO, serving farmers and global agrochemical firms.
As of March 31, 2025, the company's operations are spread across 22 countries in six continents.
As of March 31, 2025, the company's product portfolio consisting of 140 items, including insecticides, herbicides, fungicides, fertilizers, and plant growth regulators.
The company has a network of over 14,950 active dealers who sell its products directly to farmers.
The company has six manufacturing units in India that cater to our branded formulation business and are strategically located in agrochemical hubs in western and northern India.
As of March 31, 2025, the company has one of the largest and widest product portfolios in the Indian agrochemicals industry.
As of March 31, 2025, the company employed 37 people dedicated to its quality control and process safety operations.
As of March 31, 2025, the company had a total of 1,555 full-time employees in various departments.
Competitive Strength:
- Differentiated Business Model with a Presence Across the Agrochemical Value Chain.
- Unique multi-brand strategy with a Pan-India Direct Distribution Network in our Branded Formulation Business.
- Robust Product Portfolio in the Speciality Chemicals Business.
- CDMO Business with Established Relationships with Global Agrochemical Companies.
- Efficient Working Capital Cycle.
- Experienced Promoters and Senior Management Team and Investor.
Strength Of Safex Chemicals India IPO
Risk Of Safex Chemicals India IPO
Objectives Safex Chemicals India IPO
1. Repayment/prepayment, in part or full, of certain of or all of borrowings availed by the Company;
2. Repayment/prepayment, in part or full, of certain of or all of borrowings availed by Subsidiary, namely, Shogun Organics, through investments in such Subsidiary
3. General corporate purposes
Company Contact Details
Safex Chemicals India Limited
4th & 5th Floor
Block-A, NDM-1
Netaji Subash Place,
North West Delhi, New Delhi, 110034
Phone: +91 11 6610 5000
Email: cs@safexchemicals.com
Website: https://safexchemicals.com/
Registrar Contact Details
Safex Chemicals India IPO - FAQs
The Safex Chemicals India IPO is a MAINBOARD public issue comprising 0 equity shares with a face value of ₹1 each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is 0 shares.
The IPO opens for subscription on TBA, and closes on TBA.
Kfin Technologies Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
As of now, the current GMP stands at TBA.